A synthetic strategy using Witkop's pyrroloindole for (-)-debromoflustramine B, (+)-ent-debromoflustramine B and (+)-ent-debromoflustramide B

Tetrahedron

Volumn 63, Issue 41, 2007, Pages 10211-10225

  Cardoso, A Sofia P ^a,b   Marques, M Manuel B ^a,c   Srinivasan, Natarajan ^a   Prabhakar, Sundaresan ^a,c   Lobo, Ana M ^a,c  

^a DEPARTAMENTO DE QUÍMICA   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^c UNINOVA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

(2,3A) 1 ACETYL 3A (3 METHYL 2 BUTENYL) 2 METHOXYCARBONYL 1,2,3,3A TETRAHYDROPYRROLO[2,3B]INDOLE; (2,3A) 8 ACETYL 3A (3 METHYL 2 BUTENYL) 2 METHOXYCARBONYL 2,3,3A,8 TETRAHYDROPYRROLO[2,3B]INDOLE; (2,3A) 8 METHYL 3A (3 METHYL 2 BUTENYL) 2 METHOXYCARBONYL 2,3,3A,8 TETRAHYDROPYRROLO[2,3B]INDOLE; (2,3A)1 ACETYL 3A (3 METHYL 2 BUTENYL)2 METHOXYCARBONYL 1,2,3,3A TETRAHYDROPYRROLO[2,3 B]INDOLE; (3A,8A) 3A,8 BIS(3 METHYL 2 BUTENYL) 3,3A,8,8A TETRAHYDROPYRROLO[2,3 B]INDOLE; (3A,8A) 3A,8 BIS(3 METHYL 2 BUTENYL)3,3A,8,8A TETRAHYDROPYRROLO[2,3 B]INDOLE; 1,3 BIS(3 METHYL 2 BUTENYL) 1H INDOLE; INDOLE DERIVATIVE; PRENYLAMINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CYCLIZATION; MOLECULAR DYNAMICS; PRENYLATION; PRIORITY JOURNAL; SYNTHESIS;

EID: 34548306948     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.07.091     Document Type: Article

References (51)

1. Anthoni U., Christophersen C., and Nielsen P.H. In: Pelletier S.W. (Ed). Alkaloids: Chemical and Biological Perspectives (1999), Pergamon, New York, NY pp 113, 163
2. Wright J.L.C. J. Nat. Prod. 47 (1984) 893
3. Holst P.B., Anthoni U., Christophersen C., and Nielsen P.H. J. Nat. Prod. 57 (1994) 997
4. Carlé J.S., and Christophersen C. J. Org. Chem. 45 (1980) 1586
5. Muthusubramanian P., Carlé J.S., and Chistophersen C. Acta Chem. Scand. B 37 (1983) 803
6. Keil P., Nielsen E.G., Anthoni U., and Christophersen C. Acta Chem. Scand. B 40 (1986) 555
7. Carlé J.S., and Christophersen C. J. Org. Chem. 46 (1981) 3440
8. For a review of the pharmacology of physostigmine, see:. Brossi A. J. Med. Chem. 33 (1990) 2311
9. Takase S., Iwami M., Ando T., Okamoto M., Yoshida K., Horiai H., Kohsaka M., Aoki H., and Imanaka H. J. Antibiot. 37 (1984) 1320
10. Karwowski J.P., Jackson M., Rasmussen R.R., Humphrey P.E., Poddig J.B., Kohl W.L., Scherr M.H., Kadam S., and McAlpine J.B. J. Antibiot. 46 (1993) 374
11. Such an approach involving a Claisen rearrangement of an oxindole derivative for syntheses of (-)-flustramines and (-)-flustramides has been reported, see:
12. Kawasaki T., Shinada M., Kamimura D., Ohzono M., and Ogawa A. Chem. Commun. (2006) 420
13. Kawasaki T., Terashima R., Sakaguchi K., and Sakamoto M. Tetrahedron Lett. 37 (1996) 7525
14. 6b
15. For syntheses of the alkaloids, see:
16. dl-flustramines A and B:. Morales-Ríos M.S., Suárez-Castillo O.R., and Joseph-Nathan P. J. Org. Chem. 66 (2001) 1186
17. (-)-Flustramine B:. Austin J.F., Kim S.-G., Sinz C.J., Xiao W.-J., and MacMillan D.W.C. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 5482
18. dl-Flustramine and dl-flustramine C:. Fuchs J.R., and Funk R.L. Org. Lett. 7 (2005) 677
19. Ohno M., Spande T.F., and Witkop B. J. Am. Chem. Soc. 92 (1970) 343
20. For a preliminary account of the work, see:. Cardoso A.S.P., Srinivasan N., Lobo A.M., and Prabhakar S. Tetrahedron Lett. 42 (2001) 6663
21. For racemic syntheses, see:
22. Tan G.H., Zhu X., and Ganesan A. Org. Lett. 5 (2003) 1801
23. Jensen J., Anthoni U., Christophersen C., and Nielsen P.H. Acta Chem. Scand. B 49 (1995) 68
24. Somei M., Yamada F., Izumi T., and Nakajou M. Heterocycles 45 (1997) 2327
25. For asymmetric syntheses, see:
26. ent-(+)-debromoflustramine B:. Bruncko M., Crich D., and Samy R. J. Org. Chem. 59 (1994) 5543
27. (+)- and (-)-Debromoflustramines B:. Morales-Ríos M.S., Rivera-Becerril E., and Joseph-Nathan P. Tetrahedron: Asymmetry 16 (2005) 2493
28. 3a in Witkop's tricycle
29. For N-alkylation of indoles, see:
30. de Silva S.O., and Snieckus V. Can. J. Chem. 56 (1978) 1621
31. Güngör T., Malabre P., and Teulon J. Synth. Commun. 24 (1994) 2247
32. Güngör T., Malabre P., Teulon J.M., Camborde F., Meignen J., Herts F., Virone-Oddos A., Caussade F., and Cloarec A. J. Med. Chem. 37 (1994) 4307
33. Lasne M.-C., Cairon P., and Villemin D. Synth. Commun. 20 (1990) 41
34. Borch R.F., Bernstein M.D., and Durst H.D. J. Am. Chem. Soc. 93 (1971) 2897
35. Barton D.H.R., Crich D., and Motherwell W.B. Tetrahedron 41 (1985) 3901
36. Barton D.H.R., Herve Y., Potier P., and Thierry J. Tetrahedron 44 (1988) 5479
37. Barton D.H.R., and Samadi M. Tetrahedron 48 (1992) 7083
38. Sforza S., Dossena A., Corradini R., Virgili E., and Marchelli R. Tetrahedron Lett. 39 (1998) 711
39. Brown H.C., and Tsukamoto A. J. Am. Chem. Soc. 86 (1964) 1089
40. Barton D.H.R., Bridon D., and Zard S.Z. J. Chem. Soc., Chem. Commun. (1985) 1066
41. Barton D.H.R., Bridon D., and Zard S.Z. Tetrahedron 45 (1989) 2615
42. Dess D.B., and Martin J.C. J. Org. Chem. 48 (1983) 4155
43. Mancuso A.J., Huang S.-L., and Swern D. J. Org. Chem. 43 (1978) 2480
44. Sneeden R.P., and Turner R.B. J. Am. Chem. Soc. 77 (1955) 190
45. Blackburn T.F., and Schwartz J. J. Chem. Soc., Chem. Commun. (1977) 157
46. Interestingly exposure of 21b to a solution of NaOMe/MeOH (2 M, 6.10 mmol) containing hydrazine (0.51 mmol) for a day, at rt, also gave 30b in a comparable yield (39%).
47. 2 as the solvent, the ion pair is likely to have more covalent character. If some electrostatic attraction between the bulky cation and the ester group is invoked (Fig. 3), then the β-face becomes more shielded and diastereoselection during alkylation becomes possible. Such an attraction, among other factors, is believed to be important in explaining the origin of the enantioselectivity in the alkylation of prochiral ketones catalysed by chiral quaternary salts of Cinchona alkaloids. For the mechanism of chiral induction, see:. In: Ojima I. (Ed). Chiral Asymmetric Synthesis (2000), Wiley-VCH, New York, NY pp 585, 736
48. Perrin D.D., Armarego W.L.F., and Perrin D.R. Purification of Laboratory Chemicals. 2nd ed. (1980), Pergamon, Oxford
49. 3 species. For examples of such reactions, see:
50. Casnati G., Marchelli R., and Pochini A. J. Chem. Soc., Perkin Trans. 1 (1974) 754
51. Cardoso A.S.P., Marques M.M.B., Srinivasan N., Prabhakar S., Lobo A.M., and Rzepa H.S. Org. Biomol. Chem. 4 (2006) 3966